Literature DB >> 22322796

[Prevention of periprosthetic joint infections].

Norbert Harrasser1, Tobias Harnoss.   

Abstract

High numbers of primary joint replacement procedures lead to increasing numbers of revision surgeries due to periprosthetic joint infections. Several studies revealed different patient-associated and intervention-associated risk factors. Importance should be pointed on short operating times to avoid intraoperative colonisation of the implant with microorganisms. Patient-associated diseases such as diabetes and obesity should be influenced positively in the preoperative setting. Cessation of smoking should be started two months before surgery and continued until wound healing is completed. Intraoperative single-shot antibiotic prophylaxis has become clinical routine. Prolonged perioperative antibiotic prophylaxis is often conducted but has not shown to be effective in lowering infection rates.

Entities:  

Mesh:

Year:  2012        PMID: 22322796     DOI: 10.1007/s10354-011-0043-2

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  45 in total

Review 1.  Treatment of infections associated with surgical implants.

Authors:  Rabih O Darouiche
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

2.  Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections.

Authors:  Sebastiano Leone; Silvio Borrè; Antonella d'Arminio Monforte; Gennaro Mordente; Nicola Petrosillo; Alberto Signore; Mario Venditti; Pierluigi Viale; Emanuele Nicastri; Francesco N Lauria; Giampiero Carosi; Mauro Moroni; Giuseppe Ippolito
Journal:  Int J Infect Dis       Date:  2010-09-16       Impact factor: 3.623

Review 3.  [Perioperative antibiotic prophylaxis. Use in orthopaedics].

Authors:  M Széll; S Hofmann; M Pietsch; E Gerhart; C Wenisch
Journal:  Orthopade       Date:  2006-07       Impact factor: 1.087

4.  Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat.

Authors:  Pierre Vaudaux; William L Kelley; Daniel P Lew
Journal:  Clin Infect Dis       Date:  2006-09-08       Impact factor: 9.079

5.  [Minimally invasive total hip arthroplasty - trend or state of the art?: A meta-analysis].

Authors:  T Kappe; R Bieger; D Wernerus; H Reichel
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

6.  Can this prosthesis be saved?: implant salvage attempts in infected primary TKA.

Authors:  Jeremy Gardner; Terence J Gioe; Penny Tatman
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

Review 7.  Perioperative lower urinary tract infections and deep sepsis in patients undergoing total joint arthroplasty.

Authors:  T S David; M S Vrahas
Journal:  J Am Acad Orthop Surg       Date:  2000 Jan-Feb       Impact factor: 3.020

8.  Ultraclean air and antibiotics for prevention of postoperative infection. A multicenter study of 8,052 joint replacement operations.

Authors:  O M Lidwell; R A Elson; E J Lowbury; W Whyte; R Blowers; S J Stanley; D Lowe
Journal:  Acta Orthop Scand       Date:  1987-02

9.  The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty.

Authors:  Milford H Marchant; Nicholas A Viens; Chad Cook; Thomas Parker Vail; Michael P Bolognesi
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

10.  Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register.

Authors:  Lars B Engesaeter; Stein Atle Lie; Birgitte Espehaug; Ove Furnes; Stein Emil Vollset; Leif Ivar Havelin
Journal:  Acta Orthop Scand       Date:  2003-12
View more
  1 in total

1.  Does Preoperative Antimicrobial Prophylaxis Influence the Diagnostic Potential of Periprosthetic Tissues in Hip or Knee Infections?

Authors:  Klemen Bedenčič; Martina Kavčič; Nataša Faganeli; Rene Mihalič; Blaž Mavčič; Jožica Dolenc; Zlatka Bajc; Rihard Trebše
Journal:  Clin Orthop Relat Res       Date:  2015-08-08       Impact factor: 4.176

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.